BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18821203)

  • 1. Changes of leukocyte adherence ability under the influence of magnetic field in the course of a treatment of patients with laryngeal and pharyngeal carcinoma.
    Cocek A; Hahn A; Ambrus M; Dohnalová A; Jandová A; Pokorný J
    Electromagn Biol Med; 2008; 27(3):277-88. PubMed ID: 18821203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of lower induction values of 50 Hz external electromagnetic fields on in vitro T lymphocyte adherence capabilities.
    Coček A; Hahn A; Mártonová J; Ambruš M; Dohnalová A; Nedbalová M; Jandová A
    Electromagn Biol Med; 2012 Jun; 31(2):166-77. PubMed ID: 22268989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells.
    Berlinger NT; Hilal EY; Oettgen HF; Good RA
    Laryngoscope; 1978 Mar; 88(3):470-83. PubMed ID: 146766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
    Niksić M; Balogh M
    Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processes and outcomes of head and neck cancer patients from geographically disparate regions of the UK. A comparison of Scottish and English cohorts.
    MacKenzie K; Savage SA; Birchall MA
    Eur J Surg Oncol; 2009 Oct; 35(10):1113-8. PubMed ID: 19406610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The LDH virus and changes in cellular immunity in schizophrenics and their relatives].
    Dvoráková M; Zvolský P; Jandová A
    Sb Lek; 1990 Oct; 92(10):305-10. PubMed ID: 2263869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity in cervical cancer evolution.
    Jandová A; Pokorný J; Kobilková J; Janousek M; Masata J; Trojan S; Nedbalová M; Dohnalová A; Beková A; Slavík V; Cocek A; Sanitrák J
    Electromagn Biol Med; 2009; 28(1):1-14. PubMed ID: 19337890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perception of head and neck cancer quality of life within the medical world: a multicultural study.
    Demez PH; Moreau PR
    Head Neck; 2009 Aug; 31(8):1056-67. PubMed ID: 19340871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High endothelial venules are present in pharyngeal and laryngeal carcinomas and they are associated with better prognosis.
    Karpathiou G; Dumollard JM; Gavid M; Casteillo F; Vieville M; Prades JM; Froudarakis M; Peoc'h M
    Pathol Res Pract; 2021 Apr; 220():153392. PubMed ID: 33647862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of various immunologic indicators in patients with laryngopharyngeal cancer before and after administration of T-activin].
    Nummaev GM; Drevnina NA
    Vestn Otorinolaringol; 1989; (1):67. PubMed ID: 2785312
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological surveillance of otorhinolaryngological cancers].
    Bagarry D; Favre R; Imbert J; Jausseran M; Meyer G; D'Istria JC; Serafino X
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Dec; 23(10):852-9. PubMed ID: 4282092
    [No Abstract]   [Full Text] [Related]  

  • 14. [An immuno-biological approach to the problem of the metastatic spread of cancers of the neck].
    Babighian G
    Rev Laryngol Otol Rhinol (Bord); 1974; 95(1-2):103-15. PubMed ID: 4421254
    [No Abstract]   [Full Text] [Related]  

  • 15. Blastic transformation of blood lymphocytes in patients with laryngeal carcinoma.
    Urasiński I; Krygier-Stojalowska A; Mozolewski E; Koselnik-Glugla B; Wasilewska M
    Pol Med Sci Hist Bull (1973); 1976; 15(1):83-6. PubMed ID: 995760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spontaneous adhesion of blood leukocytes in cancer patients and healthy subjects].
    Zherbin EA; Komar VE; Simbbirtseva LP; Kopytova LI; Nikolaevskaia LV
    Vopr Onkol; 1988; 34(12):1443-8. PubMed ID: 3218147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of alpha-1-antitrypsin in patients with laryngeal carcinoma].
    Niksić-Ivancić M; Oresković M
    Laryngol Rhinol Otol (Stuttg); 1983 Jun; 62(6):246-8. PubMed ID: 6412008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
    Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
    Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus in early laryngeal carcinoma.
    Baumann JL; Cohen S; Evjen AN; Law JH; Vadivelu S; Attia A; Schindler JS; Chung CH; Wirth PS; Meijer CJ; Snijders PJ; Yarbrough WG; Slebos RJ
    Laryngoscope; 2009 Aug; 119(8):1531-7. PubMed ID: 19489068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.